Amisulpride Thame 100mg/ml Sugar Free Oral Solution Malta - angielski - Malta Medicines Authority

amisulpride thame 100mg/ml sugar free oral solution

syri pharma limited floor 0 1 wml, 1 windmill lane dublin 2, d02 f206, ireland - amisulpride - oral solution - amisulpride 100 mg/ml - psycholeptics

SOLIAN 100 amisulpride 100 mg tablet blister pack Australia - angielski - Department of Health (Therapeutic Goods Administration)

solian 100 amisulpride 100 mg tablet blister pack

sanofi-aventis australia pty ltd - amisulpride, quantity: 100 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate type a; lactose monohydrate; hypromellose; magnesium stearate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

SOLIAN 100 MG Izrael - angielski - Ministry of Health

solian 100 mg

sanofi israel ltd - amisulpride - tablets - amisulpride 100 mg - amisulpride - amisulpride - treatment of schizophrenia .

Amisulprid Sandoz 100 mg tabl. Belgia - angielski - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

amisulprid sandoz 100 mg tabl.

sandoz sa-nv - amisulpride 100 mg - tablet - 100 mg - amisulpride 100 mg - amisulpride

Solian 100 mg tabl. Belgia - angielski - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

solian 100 mg tabl.

sanofi belgium sa-nv - amisulpride 100 mg - tablet - 100 mg - amisulpride 100 mg - amisulpride

Amisulpride Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

amisulpride

max health limited - amisulpride 100mg - tablet - 100 mg - active: amisulpride 100mg excipient: lactose monohydrate magnesium stearate methylcellulose microcrystalline cellulose sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

AMISULPRIDE WINTHROP amisulpride 100mg/mL oral solution bottle Australia - angielski - Department of Health (Therapeutic Goods Administration)

amisulpride winthrop amisulpride 100mg/ml oral solution bottle

sanofi-aventis australia pty ltd - amisulpride -

AMISULPRIDE 50 WINTHROP amisulpride 50 mg tablet blister pack Australia - angielski - Department of Health (Therapeutic Goods Administration)

amisulpride 50 winthrop amisulpride 50 mg tablet blister pack

sanofi-aventis australia pty ltd - amisulpride -

APOTEX-Amisulpride 100 mg tablet blister pack Australia - angielski - Department of Health (Therapeutic Goods Administration)

apotex-amisulpride 100 mg tablet blister pack

gm pharma international pty ltd - amisulpride, quantity: 100 mg - tablet - excipient ingredients: lactose monohydrate; sodium starch glycollate type a; magnesium stearate; methylcellulose; microcrystalline cellulose - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

SOLIAN TABLET 100 mg Singapur - angielski - HSA (Health Sciences Authority)

solian tablet 100 mg

sanofi-aventis singapore pte. ltd. - amisulpride - tablet, film coated - 100 mg - amisulpride 100 mg